Adoption rates of immune checkpoint inhibitors in real world oncology practice.

e15103Background: Inhibition of immune checkpoints such as PD-1, PD-L1, and CTLA-4, has become an important option in unleashing the immune system to fight cancer. However, there is limited informa...